GAP vs IONS · P/E 9.9, rev $15.09B vs rev $226.6M
The Gap, Inc. (GAP) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
GAP currently screens at market cap $7.73B and trailing P/E 9.9. IONS currently screens at market cap $12.28B.
Not investment advice. Open the GAP and IONS stock pages for the full models.
Not investment advice.